Clinical Trial Update: Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a tegoprazan-based triple eradication therapy to esomeprazole for Helicobacter pylori infection; efficacy and safety data are being eval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Tegoprazan-based triple eradication therapy (tegoprazan-based triple eradication therapy)

Snippet

Sponsor: Hospital General de México Dr. Eduardo Liceaga | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN